BerandaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
$0,95
Rentang hari
$0,91 - $1,00
Rentang tahun
$0,65 - $1,58
Kapitalisasi pasar
36,55 jt USD
Volume Rata-Rata
31,89 rb
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 12,64 jt | 118,55% |
Laba bersih | -19,65 jt | -26,85% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,49 | -22,50% |
EBITDA | -19,36 jt | -21,86% |
Tarif pajak efektif | 0,11% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 99,12 jt | -23,74% |
Total aset | 142,00 jt | -28,82% |
Total liabilitas | 26,40 jt | -3,87% |
Total ekuitas | 115,59 jt | — |
Saham yang beredar | 40,34 jt | — |
Harga terhadap nilai buku | 0,33 | — |
Tingkat pengembalian aset | -34,07% | — |
Tingkat pengembalian modal | -38,19% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,65 jt | -26,85% |
Kas dari operasi | -14,90 jt | -26,05% |
Kas dari investasi | -5,00 rb | 98,38% |
Kas dari pembiayaan | 2,00 rb | -99,60% |
Perubahan kas bersih | -11,82 jt | 2,46% |
Arus kas bebas | -9,79 jt | -67,99% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
105
